Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
biochemistry, genetics and molecular biology
Continuous interstitial glucose monitoring in non-diabetic subjects with end-stage renal disease undergoing maintenance haemodialysis
Diabetes Research and Clinical Practice, Volume 90, No. 1, Year 2010
Notification
URL copied to clipboard!
Description
Haemodialysis improves uraemia-induced insulin sensitivity and is therefore likely to induce significant changes in circulating glucose concentrations in end-stage renal disease (ESRD). We aimed to assess clinically relevant circulating glucose changes in patients undergoing chronic maintenance haemodialysis using continuous interstitial monitoring. We investigated 14 non-diabetic ESRD subjects aged 40.6 ± 2.4 years. Participants were examined 24-h day pre-dialysis, during the index dialysis session and 24-h post-dialysis with simultaneous measurement of capillary blood glucose and continuous interstitial glucose (CGMS). Participants performed five capillary blood glucose measurements the day before dialysis, and 10 during and after dialysis. Mean capillary blood glucose was 128 ± 20. mg/dl the day before, 93 ± 8. mg/dl during haemodialysis, and 105 ± 13. mg/dl after haemodialysis. There was a significant trend towards lower blood glucose during the session from 105 ± 16. mg/dl to a 3rd hour nadir of 83 ± 15. mg/dl (Anova F= 2.89, p= 0.029). No hypoglycaemia was recorded. Interstitial glucose profile was comparable to capillary glucose profile. Glucose concentrations varied significantly from 126 ± 13. mg/dl before to 112 ± 12. mg/dl after haemodialysis respectively (p= 0.006). This study provides evidence for the use of CGMS in ESRD and haemodialysis, and demonstrates significant changes in glucose concentrations during and after haemodialysis that would guide treatment monitoring and adjustments. © 2010.
Authors & Co-Authors
Sobngwi, Eugène
Cameroon, Yaounde
Université de Yaoundé I
United Kingdom, Newcastle
University of Newcastle Upon Tyne, Faculty of Medical Sciences
Ashuntantang, Gloria Enow
Cameroon, Yaounde
Université de Yaoundé I
Ndounia, E.
Cameroon, Yaounde
Université de Yaoundé I
Dehayem, Mesmin Yefou
Cameroon, Yaounde
Université de Yaoundé I
Azabji-Kenfack, Marcel
Cameroon, Yaounde
Université de Yaoundé I
Kaze, François Folefack
Cameroon, Yaounde
Université de Yaoundé I
Balti Vounsia, Eric
Cameroon, Yaounde
Université de Yaoundé I
Mbanya, J. C.
Cameroon, Yaounde
Université de Yaoundé I
Statistics
Citations: 30
Authors: 8
Affiliations: 2
Identifiers
Doi:
10.1016/j.diabres.2010.06.001
ISSN:
01688227
Research Areas
Noncommunicable Diseases